Cargando…

NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma

BACKGROUND: Radiotherapy is the first-line regimen for treating oral squamous cell carcinoma (OSCC) in current clinics. However, the development of therapeutic resistance impacts the anticancer efficacy of irradiation in a subpopulation of OSCC patients. As a result, discovering a valuable biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Tsu-Zong, Lin, Hui-Yu, Kuei, Chia-Hao, Lin, Che-Hsuan, Lee, Hsun-Hua, Lee, Hsin-Lun, Lu, Hsiao-Wei, Su, Chia-Yi, Chiu, Hui-Wen, Lin, Yuan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993556/
https://www.ncbi.nlm.nih.gov/pubmed/36890567
http://dx.doi.org/10.1186/s12935-023-02883-0
_version_ 1784902540818644992
author Yuan, Tsu-Zong
Lin, Hui-Yu
Kuei, Chia-Hao
Lin, Che-Hsuan
Lee, Hsun-Hua
Lee, Hsin-Lun
Lu, Hsiao-Wei
Su, Chia-Yi
Chiu, Hui-Wen
Lin, Yuan-Feng
author_facet Yuan, Tsu-Zong
Lin, Hui-Yu
Kuei, Chia-Hao
Lin, Che-Hsuan
Lee, Hsun-Hua
Lee, Hsin-Lun
Lu, Hsiao-Wei
Su, Chia-Yi
Chiu, Hui-Wen
Lin, Yuan-Feng
author_sort Yuan, Tsu-Zong
collection PubMed
description BACKGROUND: Radiotherapy is the first-line regimen for treating oral squamous cell carcinoma (OSCC) in current clinics. However, the development of therapeutic resistance impacts the anticancer efficacy of irradiation in a subpopulation of OSCC patients. As a result, discovering a valuable biomarker to predict radiotherapeutic effectiveness and uncovering the molecular mechanism for radioresistance are clinical issues in OSCC. METHODS: Three OSCC cohorts from The Cancer Genome Atlas (TCGA), GSE42743 dataset and Taipei Medical University Biobank were enrolled to examine the transcriptional levels and prognostic significance of neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8). Gene set enrichment analysis (GSEA) was utilized to predict the critical pathways underlying radioresistance in OSCC. The colony-forming assay was used to estimate the consequences of irradiation sensitivity after the inhibition or activation of the NEDD8-autophagy axis in OSCC cells. RESULTS: NEDD8 upregulation was extensively found in primary tumors compared to normal adjacent tissues and potentially served as a predictive marker for the therapeutic effectiveness of irradiation in OSCC patients. NEDD8 knockdown enhanced radiosensitivity but NEDD8 overexpression reduced it in OSCC cell lines. The inclusion of MLN4924, a pharmaceutical inhibitor for NEDD8-activating enzyme, dose-dependently restored the cellular sensitivity to irradiation treatment in irradiation-insensitive OSCC cells. Computational simulation by GSEA software and cell-based analyses revealed that NEDD8 upregulation suppresses Akt/mTOR activity to initiate autophagy formation and ultimately confers radioresistance to OSCC cells. CONCLUSION: These findings not only identify NEDD8 as a valuable biomarker to predict the efficacy of irradiation but also offer a novel strategy to overcome radioresistance via targeting NEDD8-mediated protein neddylation in OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02883-0.
format Online
Article
Text
id pubmed-9993556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99935562023-03-09 NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma Yuan, Tsu-Zong Lin, Hui-Yu Kuei, Chia-Hao Lin, Che-Hsuan Lee, Hsun-Hua Lee, Hsin-Lun Lu, Hsiao-Wei Su, Chia-Yi Chiu, Hui-Wen Lin, Yuan-Feng Cancer Cell Int Research BACKGROUND: Radiotherapy is the first-line regimen for treating oral squamous cell carcinoma (OSCC) in current clinics. However, the development of therapeutic resistance impacts the anticancer efficacy of irradiation in a subpopulation of OSCC patients. As a result, discovering a valuable biomarker to predict radiotherapeutic effectiveness and uncovering the molecular mechanism for radioresistance are clinical issues in OSCC. METHODS: Three OSCC cohorts from The Cancer Genome Atlas (TCGA), GSE42743 dataset and Taipei Medical University Biobank were enrolled to examine the transcriptional levels and prognostic significance of neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8). Gene set enrichment analysis (GSEA) was utilized to predict the critical pathways underlying radioresistance in OSCC. The colony-forming assay was used to estimate the consequences of irradiation sensitivity after the inhibition or activation of the NEDD8-autophagy axis in OSCC cells. RESULTS: NEDD8 upregulation was extensively found in primary tumors compared to normal adjacent tissues and potentially served as a predictive marker for the therapeutic effectiveness of irradiation in OSCC patients. NEDD8 knockdown enhanced radiosensitivity but NEDD8 overexpression reduced it in OSCC cell lines. The inclusion of MLN4924, a pharmaceutical inhibitor for NEDD8-activating enzyme, dose-dependently restored the cellular sensitivity to irradiation treatment in irradiation-insensitive OSCC cells. Computational simulation by GSEA software and cell-based analyses revealed that NEDD8 upregulation suppresses Akt/mTOR activity to initiate autophagy formation and ultimately confers radioresistance to OSCC cells. CONCLUSION: These findings not only identify NEDD8 as a valuable biomarker to predict the efficacy of irradiation but also offer a novel strategy to overcome radioresistance via targeting NEDD8-mediated protein neddylation in OSCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-023-02883-0. BioMed Central 2023-03-08 /pmc/articles/PMC9993556/ /pubmed/36890567 http://dx.doi.org/10.1186/s12935-023-02883-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yuan, Tsu-Zong
Lin, Hui-Yu
Kuei, Chia-Hao
Lin, Che-Hsuan
Lee, Hsun-Hua
Lee, Hsin-Lun
Lu, Hsiao-Wei
Su, Chia-Yi
Chiu, Hui-Wen
Lin, Yuan-Feng
NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title_full NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title_fullStr NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title_full_unstemmed NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title_short NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
title_sort nedd8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9993556/
https://www.ncbi.nlm.nih.gov/pubmed/36890567
http://dx.doi.org/10.1186/s12935-023-02883-0
work_keys_str_mv AT yuantsuzong nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT linhuiyu nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT kueichiahao nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT linchehsuan nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT leehsunhua nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT leehsinlun nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT luhsiaowei nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT suchiayi nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT chiuhuiwen nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma
AT linyuanfeng nedd8promotesradioresistanceviatriggeringautophagyformationandservesasanovelprognosticmarkerinoralsquamouscellcarcinoma